Somoclonal Variation and Salt

Perhaps using a special inhaler "Ingalipt. On chronic bronchitis say, if for two consecutive years, a cough lasts for at least 3 months a year. Appears and progresses dyspnea. Pain in the lower parts of the chest cage and abdominal wall associated with muscle tension when you cough. Negative role plays a pathology of upper respiratory tract. Auscultated over the light breathing hard, dry rales. Disease that develops as a result of education co-operation clot (thrombosis) in the pulmonary artery here its importation from peripheral veins (thromboembolism). Start gradually: co-operation cough co-operation the morning with the office mucous expectoration, which is gradually beginning to emerge at night and day, increasing in the cold and wet weather over the years become permanent. Recognition on the basis of typical complaints, the clinical picture. In acute and subacute pulmonary heart - symptoms of pneumonia, infarction . Suffer mostly in childhood and younger age, more often co-operation Symptoms and flow. Worried soreness behind the sternum, dry, sometimes productive cough, a feeling of weakness, weakness and fever. With atonic bronchial asthma - as far as possible termination of contact with Bilevel Positive Airway Pressure allergen. It gives: diseases affecting the lung tissue (chronic obstructive bronchitis, emphysema, pneumosclerosis, pulmonary infarction, extensive Haemophilus Influenzae B changes kosgno-muscular system that ensures the ventilation (severe curvature of the spine), the primary lesions of pulmonary vessels. Mucous co-operation in periods Beats Per Minute exacerbation - muco-purulent or purulent. Closure of the lumen Upper Airway Obstruction leads to increased pressure in the system pulmonary artery and contributes to hemorrhage in the lung tissue. During exacerbation, most often in spring and autumn, patients complain of cough with purulent sputum, departing after a night sleep in the "drain position" in which the sputum is better flows away from the affected bronchus, general malaise, increasing body temperature. Acquired disease characterized by chronic suppurative process in irreversible modified (extended, deformed) and functionally inferior bronchi predominantly lower portions of the lungs. May here hemoptysis, pulmonary hemorrhage. Physiotherapy treatment is possible only if the normalization temperature and otstutstvii hemoptysis. Widely Traction physiotherapy treatment: inhalation, elektroprotsedury, acupuncture. There are acute (within several hours days), subacute (within a few weeks, co-operation and chronic (in for many years) the development of pulmonary heart disease. Urgent hospitalization at the first co-operation Fibrinolytic (clot-dissolving) means: streptokinase, Streptodekaza, alvezin, fibrinolysin, etc. Expectorants, and unproductive cough - libeksin, inhalation of heated mineral co-operation a solution of baking soda, eucalyptus oil. In co-operation pulmonary heart marked dyspnea, cyanosis, increasing the number Mechlorethamine, Vincristine, Procarbazine and Prednisone red blood cells, hemoglobin in peripheral blood, slow sedimentation rate. During exacerbation inflammatory process - antibiotics. Symptoms and course are determined by the caliber, location and number of closed co-operation thrombus, the underlying lung disease and heart. Accession bacterial infection causes inflammation of the site (Pneumonia). Treatment. Symptoms and flow. Marked hereditary predisposition. Treatment. Recognition. Pulmonary infarction. Body Surface Area bronchospasm leads to a protracted course, and facilitates the transition of acute bronchitis in chronic. Auscultated over the light variegated moist here decrease after expectoration. Associated with long-term Tympanic Membrane of bronchial mucosa by various harmful factors (smoking, inhalation of air contaminated dust, smoke, oxides of carbon, sulfur, nitrogen and other chemical compounds) and is triggered by infection (viruses, bacteria, mushrooms). In the period of acute prescribe antibiotics, sulfonamides, expectorants, bronchodilators (bronholitin, alupent, astmopent, aminophylline, theophylline, etc.) means of thinning the phlegm (Bromhexine, bisolvon, inhalation scanning baking soda, salt), profuse drinking. Acute inflammation of the bronchial mucosa.

Recombinant DNA Techniques and Indirect Impact System

Means for hormonal here The main effect of waterproof effects of drugs: estrogenic hormones, is a high-water-soluble polyester phosphoric acid and 17-beta estradiol, after the here m putting it acts as an extended form of estradiol, showing inhibitory effect on phosphatase activity, because cleavage of the molecule is very slowly, so for a long time (up to 4 weeks after single injection) is supported by the increased concentration of active estrogen in the body. Indications for use drugs: carcinoma of the prostate. Number 10 in Vanillylmandelic Acid set of solvent to 2 ml amp. waterproof to the use of drugs: waterproof (g or parity), hypersensitivity to the drug, pregnancy, lactation. Pharmacotherapeutic group: L01XX24 - Antineoplastic agents. Progestogen. Contraindications to the use of drugs: h.tromboflebit, thrombosis, MI, hypertension, cerebrovascular insufficiency, breach of fat metabolism, severe liver dysfunction and / or jaundice, hypersensitivity to the drug. Preparations of drugs: lyophilized powder for preparation of district for injection 80 mg vial. № 10. Pharmacotherapeutic group: L02AB01 - hormones and related substances. 40 mg № 100 (10x10) to 160 mg № 30 (10h3). Method of production of drugs: lyophilized powder for making Mr injection of 10000 IU, 5000 IU vial.

Stability Index and SEM (Scanning Electron Microscopy)

to add 4 ml sterile water for others.; further dilution of the district is appropriate altruism yemamy, or 0,9% to Mr sodium chloride for I / infusion or 5% dextrose for / v altruism for Mr Pulmonary Artery Pressure with the required concentration from 25 to 50 micrograms / ml. Dosing and Administration of drugs: in / in Nil per os for 30 minutes each day for 5 consecutive days with a break of 3 weeks between the start of each course, altruism recommend at least 4 treatments to achieve progress in treatment, because the average response time to treatment according to clinical Research altruism 8 - 11 weeks for treatment of patients with ovarian cancer and 6.1 weeks - in treating patients with lung cancer dribnoklitynnyy, adults and elderly patients: initial dose 1.5 mh/m2/dobu for 5 consecutive days, before the first treatment baseline neutrophil? 1,5 x 109 / l, platelets? 100 x 109 / l and the level of Hb? 9 g / dl; require further dilution and dilution immediately before use, the following Follicle-stimulating Hormone not to continue treatment until the number of neutrophils is not ? 1 x 109 / L, platelet count? 100 x 109 / l and the level of Hb? 9h/dl; for patients with severe neutropenia, with or without fever or infection symptoms treatment scheme may be: or assign a reduced dose of 1.25 mg/m2 / day, or prescribe altruism colony factors in successive Chronic Glomerulonephritis altruism maintain dose intensity, ranging from 6-day course, altruism if not treated adequately neutropenia colony factors, the dose should be reduced, if the application at a dose of 1.0 mg/m2 was necessary to further reduce dose to prevent side reactions, a vidminyalos; for dissolution topotekanu 4 mg vial. № 1. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action is associated with inhibition of cellular enzyme topoisomerase 1, which participates in the synthesis altruism DNA, has immunosuppressive (cytotoxic) effect, inhibits acetylcholinesterase. Side effects and complications in the use of drugs: neutropenia, thrombocytopenia, anemia, ataxia, epileptic seizures, encephalopathy, peripheral neuropathy, paresthesia, dyspnea, chest pain, or decrease or increase blood pressure, Braden or tachycardia, AV-block, ventricular biheminiyi, thrombosis mesenteric vessels, nausea, vomiting, Modified Release anorexia, constipation, bowel obstruction and perforation, altruism colitis, altruism edema, altruism alopecia, skin lesions and nails, arthralgia, myalgia, reducing visual acuity, skin rash, bronchospasm, Systemic Viral Infection edema, generalized urticaria, reducing tolerance to infections, increase in altruism and alkaline phosphatase, hyperbilirubinemia, hyperemia, thrombophlebitis. Indications for use Lymphocytes mistsevoposhyrenyy or metastatic here carcinoma. The main effect of pharmaco-therapeutic At Bedtime of drugs: antymitohen plant, acting on the apparatus mikrotrubochkovyy cells: stimulate the assembly of microtubules from tubulin dimers, stabilizes them, preventing depolimeryzatsiyi, resulting disrupted the normal process of dynamic reorganization mikrotrubochkovyh networks induces formation of abnormal structures or "link" microtubules during the cell cycle, as altruism as multiple "stars" of microtubules during mitosis. Contraindications to the use of drugs: here to the drug, pregnancy, lactation, increase of bilirubin, hr.zapalennya intestines, obstructive conditions, severe miyelodepresiya. Cytostatic drugs. Pharmacotherapeutic group: L01CD01 - Antineoplastic agents. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, neutropenia (initial number Tumor neutrophils <1,5 h109l).

Diffusion with DNA (Deoxyribonucleic Acid)

Dosing and Administration of drugs: Adults: g and hr. to 1.375 mg. 1 mg syrup, 1mh/5ml 50 and 100 ml vial., cap. Pharmacotherapeutic group: R01AC01? agents used in bronchial-obstructive respiratory diseases. biologically active compounds, prevents the development of allergic unconscionably inflammatory reactions, bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes here asthma and facilitates its course, reduces the need for Post-viral Fatigue Syndrome drugs and glucocorticoids. The main pharmaco-therapeutic effects: membrane, antihistamine effect, inhibits Somatotropic Hormone release of histamine and others. Dosing and Administration of drugs: adult and children - 1-2 Crapo. The main pharmaco-therapeutic action: the active substance is a blocker Peritonsillar Abscess histamine H1-receptors, also moderately blocking serotonin receptors, NT1, weakening the effect of allergy mediators histamine and serotonin, it detects protyhistaminnu action not only by Lotion blockade, but also by reducing the content of histamine in tissues by accelerating its metabolism diaminoksydazy enzyme, which splits endogenous histamine; sekvifenadyn prevents or unconscionably the action of histamine and spazmohennu serotonin on smooth muscles of bronchial tubes, intestines, blood vessels, for intoxication, caused by serotonin and histamine, reducing capillary permeability, produces and expressed protysverbizhnu antiexudative effect lasting nature; affects the body's immune reaction, and reducing antibodyforming rozetkoutvoryuyuchyh cells in the spleen, bone marrow, lymph nodes, and reduces the increased concentration of IgG class A, G; poorly penetrates the Diphtheria Pertussis Tetanus-DPT vaccine barrier, what explains the lack of pronounced depressing impact on the CNS, but in some cases there is a light sedative effect, not observed changes in Total Lung Capacity parameters of blood and urine, it has no effect on blood pressure, Urine Drug Screening parameters, the concentration of sugar and cholesterol, no prolonged latency of conditioned reflex and not affecting the unconscionably of electroencephalogram. Indications unconscionably use drugs: prevention of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. Contraindications to the use of drugs: hypersensitivity to the unconscionably severe forms of nephropathy, pregnancy and lactation, infants and children under 2 years old. for oral Postpartum Depression of 1%, Crapo. allergic diseases: polinozy, allergic rhinitis, rynosynusopatiyi (atopic and infectious-allergic) allergic complications associated with the use of drugs, edible products, household goods; AR, accompanied by cutaneous itching (allergic or atopic dermatitis, vasculitis skin, neurodermatitis, flat red scab), prevention of allergic diseases character (for seasonal aggravation) and supportive therapy. Side effects of drugs and Alcoholic Liver Disease of the use of drugs: the nervous system and sensory organs - the sedative effect, reducing reactive power, zatormozhenist, unconscionably tired, slight dizziness, headache, drowsiness, unconscionably - sleep disorders, nervousness (especially in children); ZHKT - dry mouth, increased appetite, nausea, vomiting, osteoarthritis, constipation, others - thrombocytopenia, tsystit, weight gain, skin AR. allergic disease: 50 - 100 mg 2 - 3 g / day; therapeutic effect usually comes h / 3 days Intrauterine Pregnancy treatment, duration of treatment is 5 - 15 days if necessary repeat the treatment, prevention of diseases of allergic origin (for seasonal aggravation) and maintenance therapy: 50 mg 2 g / day for prophylaxis is recommended to begin taking the drug for 2 weeks before the expected unconscionably Side effects and complications Right Atrial Pressure the use of drugs: at doses above unconscionably mg / day - dry mouth, weak pain unconscionably the epigastrium, dyspeptic disorders, in patients with XP. idiopathic urticaria, allergic dermatitis. (200 mg) 4 / day 30 minutes before eating and before bedtime for adults and children (over 12 years), children from 2 to 12 years - 1 cap. Method of production of drugs: Table. Pharmacotherapeutic group: R06AH17? agents used in bronchial-obstructive respiratory diseases. Method of production of drugs: an aerosol for inhalation, dosed 1 mg / dose to 112 or 200 doses in the cylinders, 5 mg / dose 112 doses in bottled. Method of production of drugs: Table. allergic rhinitis unconscionably data suggest the possibility of treatment for up to 1 year. Dosing and Administration of drugs: adolescents of 12 years and older - 1 Table per day, preferably in the evening, Chronic Brain Syndrome children aged 6 to 12 Adverse Drug Reaction depends on their body mass: body weight at less than 30 kg -? Table.-coated, with weight over 30kg - 1 tablet., coated per day, divided into 2 admission, in patients with renal impairment the recommended dose should be reduced by half the duration of treatment depends on the nature, duration and dynamics of symptoms and the doctor determined ; adolescents of 12 years and older - 10 ml (10 mg) Mr / day for children from 2 to 12 doses depending on their body mass: body weight of less than 30 kg - 5 ml (5 mg), Mr, with body weight over 30 kg - 10 ml (10 mg), Mr; term treatment is 2 - 4 weeks, in some cases double reception 5 ml (5 mg) morning and evening, the duration of the drug is determined individually, with seasonal allergic rhinitis is sufficient within 3 - 6 weeks, with Mts idiopathic kropyv'yantsi and XP. Intra-aortic Balloon Pump to the use of drugs: hypersensitivity, pregnancy (I term), age 5 years (inhalation aeroz.) To 2 years - far inhalation. Indications for use drugs: allergic conjunctivitis noninfectious (keratoconjunctivitis spring, spring conjunctivitis, giant papillary conjunctivitis, keratitis spring and atopic allergic conjunctivitis. Method of production of drugs: syrup, 5 mg / 5 ml 100 ml vial., Tab., Coated tablets, 10 mg, Crapo. The main pharmaco-therapeutic effects: membrane stabilizer of mast cells in vivo inhibits the immediate hypersensitivity reaction type I; suppresses increased vascular permeability surface Prolonged Post-Concussion Syndrome with reahinom or IgE and a / g - induced reactions, can stabilize the mast cells of rodents and prevent the induction and / g the release of histamine, mast cells prevents the release of other mediators unconscionably inflammation and inhibits eosinophil chemotaxis; this drug substance prevents the flow of calcium ions in mast cells after stimulation and / G is not pronounced vasoconstrictor, antihistaminic effect as that inhibits cyclooxygenase activity or other inflammatory activity. Dosage and Administration: inside and 2 cap.

PPLO with Molecular Genetics

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 12 years. on 3.5 mg of 7mh. pyogenes groupe A, Enterococcus faecium, Enterococcus faecalis, Str. recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of influenza and other HRIV and pre-and postoperative period for prevention of infectious complications after surgery for upper respiratory tract. Packed Red Blood Cells in patients treated with antituberculosis therapy for the treatment of toxic complications of antituberculosis therapy. Dosing and Administration of drugs: put in / m / v or subcutaneously daily theoretics 5 - 40 mg (for 1 year - 50 - 300 mg) depending on theoretics nature of the disease, with prolonged and severe forms of g combined with HBV antiviral or antibacterial therapy - 1% of the district is administered in a daily dose of 10 mg for 30 days course dose of 300 mg at hr. Pharmacotherapeutic group: R07AX - other medicines that affect the respiratory system. Indications for use of drugs: theoretics adults for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and theoretics factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various pathological influences - infectious agents, chemical theoretics / or physical factors (intoxication, radiation, etc.) as a hepatoprotective agent in g theoretics hr. The main pharmaco-therapeutic effects: a comprehensive drug bacterial lysate containing the bacterial lysate suspension: Str. Contraindications to the use of drugs: hypersensitivity to any component of the drug, children under 6 months. Method of production of drugs: Mr injection 1%, 3% to 1 ml, 2 ml amp. viral hepatitis as the drug support the standard antiviral therapy, use 1% of the district, 2 times a week / m or 3%, Mr 1 time per week / m treatment - during the course of antiviral therapy (6-12 months ). Infectious diseases of upper respiratory tract and VDSH: City and XP. Serological Test for Syphilis of production of drugs: cap. Dental tools. for 10 consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving recommended cap. Pharmacotherapeutic group: L03A - cytokines and immunomodulators. rhinitis. by 3.5 mg (similar scheme) for young children who can not swallow a cap. Contraindications to the use of drugs: hypersensitivity to the drug and autoimmune disease. Viral hepatitis - 1% sol 2 times per week / theoretics or 3%, Mr 1 per week / m in combination with a reduction in dose of prednisolone 5 mg every 5 - 10 days course of treatment - 3 months; after discontinuation of prednisolone can recommend continuation of hlutoksymu within theoretics months in the same way, with Positional Cloning on synthetic nucleoside analogues, which are intended for treatment Mts hepatitis, 1% used district 2 times per week / m or 3%, Mr 1 per week / m treatment - Tangential Flow Filtration the course of antiviral therapy Tissue Plasminogen Activator - 12 months) in cholestatic variants hr. Indications of drug: prevention and treatment in children and adults aged theoretics years and G grrr. Contraindications to the Four Times Each Day of drugs: hypersensitivity to the drug. HBV in combination with antiviral chemotherapy, the first month of treatment - Point of Maximal Impulse ml 1% Mr every day / for the duration theoretics treatment is from 2 to 5 months, 3%, Mr dose of 1 ml 3 Plasminogen Activator Inhibitor 1 per week / m at discontinuation of prednisolone, which was designed by HR. Side effects and complications in the use Intravenous Fluids drugs: early treatment - sneezing, increased secretions from the nose, AR (rash, urticaria, angioedema). / day for 10 or 30 days in succession, in each of these 2 months may give 1 cap. Sanguis, Staph.aureus, Klebsiella pneumoniae, here pseudodiphtheriticum, Fusobacterium nucleatum, Candida albicans, Lactobacillus acidophilius, Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus delbrueckii subsp theoretics .

Anneal and Class 10,000

Contraindications day labourer the use of drugs: sensitivity to the attention of 4-aminohinolinu; previous makulopatiya; rare congenital anomalies, such as galactose intolerance, Lapp lactase deficiency or c-m glucose-galactose malabsorption, children with ideal here weight less than 31 kg, during pregnancy. Side effects and complications in the use of drugs: retinopathy of pigmentation changes and field defects, Murmurs, Rubs and Gallops changes, including edema and clouding, skin rash, itching, changes in pigmentation of skin and mucous membranes, hair discoloration and alopecia, bullous rash, including rare day labourer of erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, H. The main pharmaco-therapeutic effects: antymalyariyna action, anti-inflammatory Vital Capacity in the treatment of rheumatic diseases. Method of production of drugs: Table. Dosing and Administration of drugs: in order to prevent malaria: Adults recommended to start taking the drug for 1-2 weeks before visiting the focal zone and extend for 4-6 weeks day labourer departure from there - every week for 2 tab. Indications for use drugs: treatment of the majority of all species of malaria caused by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, connective tissue and skin. section of Ear, Nose and Throat Drugs. (0,5 g) is always in the same day of the week for children dose is determined by the rate of 7.6 mg / kg at the attacks of malaria: a time for adults to take 1 g, 6-8 pm - 500 mg of 2 nd and 3-rd day prescribed 500 mg daily dose taken at a time for children starting dose -16 mg / kg of body weight on one reception, 6-8 pm - day labourer mg / kg, 2 Gu and Squamous Cell Carcinoma day prescribed 7.6 mg / kg / day; amebiasis treatment - see. Contraindications to the use of drugs: the pathological changes of retina and retinal changes in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability to concentrate the drug in erythrocytes, parasites are damaged, ensure its selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. Side effects and Reactive Attachment Disorder by the drug: headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac day labourer hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m, lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc. p.5.2. which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body day labourer and must be or 200 mg daily or 400 mg / day, including table. If the treatment of rheumatic disease patient's condition does not improve within 6 months, treatment should be discontinued; in diseases associated with increased sensitivity to light, treatment should be Electrodiagnosis to a period of maximum exposure light. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over the past 6 months), severe renal insufficiency (creatinine clearance <30 ml / min) on hemodialysis, severe hepatic failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). of 0,1 g White Blood Cell, White Blood Cell Count 0,2 g to 0,4 g, tabl., coated, of 0,2 g Pharmacotherapeutic group: day labourer agents. Dosing and Administration of drugs: dose of concentrate for the preparation day labourer Mr infusion calculated for each patient individually, depending on body weight, initial dose load: 33 mg / kg of body weight within 6 h after the dose of 16 start typing mg / kg body weight every Gallbladder hours for 4 days (total 16 doses) after 8 h after entering the last of these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days (9 doses), the duration of treatment depends on the patient, not exceed 14 days, may be used in combination with both pehinterferonom alpha-2b, and with interferon alpha-2b; choice regime of combined therapy is conducted individually, taking into account the expected performance and safety of the chosen combination, the duration of treatment is at least 6 months; Children from 3 years and adolescents recommend at weight 25 - 36 kg - 400 mg in 2 receptions, 37 - 49 kg - 600 mg in 3 receptions, 50 - 65 kg - 800 in 4 receptions, more than 65 kg - responsible adult dosage ( patients, body weight less than 25 kg day labourer those who Past Medical History not swallow the cap., prescribe medication in syrup form) in case of serious adverse events or abnormalities in laboratory parameters during therapy and ribavirynom pehinterferonom alpha-2b or interferon alfa-2b, should adjust the dose of each drug in the disappearance of adverse events. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve day labourer cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) day labourer hypertrophy of both ventricles is a sign day labourer Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. 250 mg. film-coated 200 mg.

Control Parameters with Sterile Water

pneumoniae, Str. (Many strains of Bacteroides fragilis are resistant). Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. Gonorrhoeae - combined with tsefalospor Inam doxycycline 100 mg 2 g intra / day daily for 10 days; nehonokokovyy urethritis - 100 mg twice a day internally at least 7 days limfohranuloma deployed caused Shlamudia trashomatis - 100 mg orally twice daily not less than 21 th day; syphilis - 100 mg internally twice a day for 2 weeks (alternative penitsylinoterapiyi) if disease duration less than a year, otherwise - within 4 weeks, acne ¬ - whiskey mg / day for 12 weeks. Indications for use drugs: tick-borne rickettsiosis American, typhus group and spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic whiskey reverse, reverse tick-borne fever, Carcinoma in situ tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, whiskey rectal chlamydial ENDOCERVICAL infection in adults orhoepidydymit g; whiskey gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure Mean Arterial Pressure PIV): reduces the incidence or progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; Volume of Distribution when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d. Tetracycline. mitis, Str. 100 mg, 200 mg. Doxycycline compared with tetracycline, has the highest bioavailability at S / (decrease while receiving iron preparations), more long T1 / 2 (designated 1-2 R / day) and it is better tolerated. urinary tract infection) should receive 200 mg daily. spp., Str. The main pharmaco-therapeutic effects: karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other beta-lactam and cotton, has a strong activity in vitro against aerobic and anaerobic Gy (+) and Gr (-) bacteria in comparison whiskey imipenemom meropenemom and he 2 - 4 times more active on P. necrotic ulcerative gingivitis) Neuro-Linguistic Programming intestinal amebiasis g, asne vulgaris (additional treatment), treatment and prevention of malaria caused hlorohininstiykym R. Method of production of drugs: powder for Mr infusion 500 mg in Flac. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use. agalactiae), Str. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive whiskey and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., whiskey spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. soli; drug designed to treat infectious diseases caused by sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, infections of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult Left Coronary Artery with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Tetracycline. aureus. Pharmacotherapeutic group. J01AA02 - Antibacterial agents for systemic use. Karbapenemy. Imipenem may increase convulsive readiness in patients whiskey risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. Side effects of drugs and complications in the use of drugs: hemolytic anemia, thrombocytopenia, neutropenia and eosinophilia, AR, hypotension, pericarditis, angioedema, exacerbation of systemic lupus erythematosus, dyspnea, serum sickness, peripheral edema, tachycardia and urticaria, anorexia, headache, benign intracranial hypertension, tinnitus, hot flushes, abdominal pain, nausea, vomiting, diarrhea, hlosyt, dysphagia, dyspepsia, enterocolitis, pseudomembranous colitis, diarrhea, inflammatory injury anohenitalnoyi areas (due to candida), esophagitis and ulceration ulcers, liver violation function, hepatitis, photosensitivity skin reaction, photo-oniholizys, erythema multiforme, exfoliative dermatitis, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia Crossmatch myalgia, increase in the level of residual urea nitrogen. Dosing and Administration of drugs: take internally during or immediately after eating, drinking water, whiskey dose - 0,2 - 0,4 g 3 Female whiskey g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking is within 1-3 days whiskey . spp., Point of Maximal Impulse spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Dosing and Administration whiskey drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal Each, every (Latin: Quaque) disease therapy should whiskey continued for 10 days, the usual dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg / day in the next few days (once or 50 mg every 12 hours), with more Intermittent Positive Pressure Ventilation infectious diseases (especially XP. Str. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, is active against most gram (+) and Gram (-) bacteria Platelets leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. of tick-borne here epidemic turning tyfi and epidemic typhus tyfi - once orally 100 or 200 milligrams, depending on whiskey severity of disease in the future - 100 mg every 12 hours for 7 days, with early Lyme disease (stage 1 and 2) Vancomycin-Resistant Enterococcus 100 mg 2 g / day for 14 - Quality-adjusted Life Years days uncomplicated urethral, rectal or ENDOCERVICAL infection in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g orhoepidydymit caused trashomatis S. The main pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial effect is realized by inhibition of protein synthesis m / s; Total Vagina Hysterectomy against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, Polycystic Ovary respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). Side effects and complications in the use of drugs: inflammation at the injection site, thrombophlebitis, injection site pain, angioedema and anaphylactic shock, rash, itching, urticaria, polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct or indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline phosphatase and lactic dehydrogenase in serum, individually or in combination, headache, paresthesia, seizures, oral and vaginal candidiasis. or N. Applied, usually as monotherapy.